TipRanks on MSN
Amgen advances olpasiran heart plaque study, highlighting a growing bet on lipoprotein(a)
Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Study Overview Amgen is launching a Phase 3 trial ...
Each imaging modality offers unique diagnostic strengths. While invasive coronary angiography remains first-line, ...
Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), announced the American College of Cardiology ...
The American College of Cardiology (ACC) and the American Heart Association (AHA) issued new scientific statements advocating use of quantified coronary plaque analyses in management of patients with ...
HealthDay on MSN
EACVI: Coronary CT angiography fractional flow reserve prognostic in coronary artery disease
For patients with coronary artery disease (CAD), coronary computed tomography angiography fractional flow reserve (FFR-CT) is ...
Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 ...
Reduced coronary blood flow, measured with an artificial intelligence-based imaging tool, predicted future cardiovascular ...
For once, cardiologists find good news in the US Centers for Medicare & Medicaid Services (CMS) annual Hospital Outpatient Prospective Payment System (HOPPS) final rule: in 2025 the payment rate for ...
The launch of Malaysia's first photon-counting computed tomography (PCCT) system signals a shift towards precision-driven and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback